English version not available. Please check the Spanish version.
Urinary symptoms decrease quality of life in patients with Parkinson’s disease
Urinary symptoms decrease quality of life in patients with Parkinson’s disease
Esmeralda Gracián-Castro 1, Nancy R. Bertado-Ramírez 2 
, Arturo García-Galicia 2 , Daniel Núñez-Corona 3, Gisela Alonso-Torres 4, Álvaro J. Montiel-Jarquín 5 , Jorge Loría-Castellanos 6
1 Facultad de Medicina, Universidad Popular Autónoma del Estado de Puebla, Puebla, México; 2 Dirección de Educación e Investigación en Salud. Hospital de Especialidades de Puebla, Instituto Mexicano del Seguro Social, Puebla, Pue., México; 3 Departamento Clínico de Urología, Centro Médico Nacional, Hospital de Especialidades Gral. de Div. Manuel Ávila Camacho, Instituto Mexicano del Seguro Social, Puebla, México; 4 Facultad de Medicina, Benemérita Universidad Autónoma de Puebla, Puebla, México; 5 Dirección de Educación e Investigación en Salud, Centro Médico Nacional Gral. de Div. Manuel Ávila Camacho, Hospital de Especialidades de Puebla, Instituto Mexicano del Seguro Social (IMSS) Puebla, México; 6 Coordinación de Proyectos Especiales en Salud, Instituto Mexicano del Seguro Social, Ciudad de México, México
*Correspondence: Arturo García-Galicia. Email: neurogarciagalicia@yahoo.com.mx
Abstract
Background: Parkinson’s disease is a progressive neurodegenerative disorder that affects multiple systems manifesting with motor and non-motor symptoms. Urinary symptoms are the most prevalent non-motor manifestations.
Objective: To compare the quality of life in patients with Parkinson’s disease according to their urinary symptomatology in a tertiary care hospital.
Method: Comparative, cross-sectional, prospective study in a third level hospital in Puebla, Mexico. Patients with a diagnosis of Parkinson’s disease, older than 30 years, both sexes, were included. The IPSS and SF-36 scales were applied. Descriptive statistics, Kruskal-Wallis and Spearman’s rho were used.
Results: Thirty-seven patients were evaluated (59.5%), with mean age 62.3 years (range: 43-84; standard deviation: 10.79). Differences in SF36 and IPSS were significant in the pain and social function domains (p < 0.05). The correlation between the domain’s physical role, pain, social function, and vitality from IPSS was significant, with rho scores from 0.28 to 0.4. The correlation between the impact on quality of life by SF-36 and IPSS was not significant (p > 0.05), except in the emotional role domain.
Conclusions: Urinary symptoms affect quality of life in the domains pain, social function, physical role, and vitality.
Keywords: Calidad de vida. Enfermedad de Parkinson. Síntomas del sistema urinario inferior.
